Drugmakers Hope New Heart Drugs Boost Sales, Revive Market



The once lucrative heart-drug market is now poised to make a comeback, but at the cost of heavy investments in research and deal making.

After watching lower-priced generics seize sales of once-highflying blood-pressure, cholesterol and other heart drugs, companies struggled to discover replacements and then win reimbursement for five-figure prices. Drugmakers are now rolling out new medicines, though their commercial prospects are uncertain.



Source link

Leave a Reply

Your email address will not be published.

%d bloggers like this: